Clinical trial
Pain Relieving Potentials of Preoperative Combination of Single Dose Oral Duloxetine and Intravenous Magnesium Sulphate in Acute and Chronic Post Mastectomy Pain: A Randomized Controlled Trial
NCT06087211 is registered in ClinicalTrials.gov with National Cancer Institute, Egypt as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pain Relieving Potentials of Preoperative Combination of Single Dose Oral Duloxetine and Intravenous Magnesium Sulphate in Acute and Chronic Post Mastectomy Pain: A Randomized Controlled Trial
- Lead sponsor
- National Cancer Institute, Egypt
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 10, 2023
- Completion date
- January 1, 2025
- Enrollment
- 90 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
duloxetine, magnesium sulphate, post-mastectomy pain syndrome